NBI
NBI is a medical device with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions
Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study)
WASP Classification in Diagnosis of Diminutive Colorectal Polyps
Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions
Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal Resection
Clinical Trials (7)
A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions
Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study)
WASP Classification in Diagnosis of Diminutive Colorectal Polyps
Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions
Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal Resection
Study of Narrow Band Imaging in the Characterization of Serrated Lesions
Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7